News about FDA, Covid vaccine, and Novavax

Novavax recognizes the vital role adult vaccination plays in helping protect public health. A recently published study by @OHENews finds that adult vaccines return the equivalent of billions of dollars to society. Learn more about the health and socio-economic benefits of adult… pic.twitter.com/276FErgwOr

Novavax is proud of our sustainable supply chain. Saponin, a critical component of our Matrix-M™ adjuvant, is purified from the bark of the Quillaja saponaria Molina tree and is sustainably harvested to reduce deforestation. Read more: www.novavax.com/who-we-are/our-commitments/environmental-social-governance-esg pic.twitter.com/7pANNhatOT

COVID-19 activity has rapidly increased over the last week. Influenza levels are also increasing. Now is the recommended time to get your influenza vaccine. Full report: www.health.nsw.gov.au/Infectious/covid-19/Pages/reports.aspx More info: www.health.nsw.gov.au/Infectious/respiratory/Pages/default.aspx pic.twitter.com/2yJJSrSo8f

We announced today that we have submitted an application to the U.S. FDA for review of our updated COVID-19 vaccine formula, targeting the SARS-CoV-2 variant JN.1. The submission is based on guidance from the U.S. FDA, which advised that COVID-19 vaccines should be updated to a… pic.twitter.com/nk21pGmK9J